Cargando…
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus
AIMS: Inflammatory osteolysis is sine-qua-non of active Charcot neuroarthropathy (CN) causing decreased foot bone mineral density (BMD) and fractures. We aimed to explore the effect of anti-inflammatory or anti-resorptive agents for effect on foot bone mineral content (BMC) and consequent long-term...
Autores principales: | Das, Liza, Rastogi, Ashu, Jude, Edward B., Prakash, Mahesh, Dutta, Pinaki, Bhansali, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575293/ https://www.ncbi.nlm.nih.gov/pubmed/34748565 http://dx.doi.org/10.1371/journal.pone.0259224 |
Ejemplares similares
-
Diabetic Foot. Part 2: Charcot Neuroarthropathy
por: Ferreira, Ricardo Cardenuto
Publicado: (2020) -
Calcitonin Gene-Related Peptide in Charcot Foot Neuroarthropathy
por: Guo, Yi, et al.
Publicado: (2022) -
An overview of Charcot’s neuroarthropathy
por: Dardari, Dured
Publicado: (2020) -
An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy
por: Ramanujam, Crystal L., et al.
Publicado: (2011) -
The pathogenesis of Charcot neuroarthropathy: current concepts
por: Larson, Shelly A. M., et al.
Publicado: (2012)